Publication | Closed Access
Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes
61
Citations
31
References
2015
Year
The biologic activity rather than the mutational status of RUNX1 might be an indicator in predicting outcome of patients with MDS and CMML.
| Year | Citations | |
|---|---|---|
Page 1
Page 1